Mesothelioma

Here is a list of clinical trials that are currently happening within the mesothelioma space.

From plans to sue the School District of Philadelphia over a mesothelioma diagnosis to Dwayne “The Rock” Johnson singing for a 3-year-old with acute lymphoblastic leukemia, here’s what is making headlines in the cancer space this week.

The same properties that make certain cancers hard to treat may also promote their death by ferroptosis, scientists at the Sloan Kettering Institute have found.

A seven-year mesothelioma survivor encourages patients with cancer to be their own advocate.

A phase 3 trial compared Keytruda versus chemotherapy for patients with advanced pretreated malignant pleural mesothelioma.

Cediranib combined with platinum-based chemotherapy helped patients live longer than placebo.

A registered dietician discussed the importance of maintaining one’s weight while going through treatment for mesothelioma.

CURE® spoke with one expert about the various treatment options and current clinical trials available to patients with mesothelioma, as well as what they have to look forward to in the future.

CURE spoke with one expert about mesothelioma symptoms that patients can be on the lookout for, as well as how to be knowledgeable about certain risk factors.

Routine use of prophylactic radiotherapy in patients with malignant pleural mesothelioma is unnecessary following a chest wall procedure, according to multicenter, open-label, phase 3, randomized controlled trial findings published in the Journal of Clinical Oncology.

Results from a clinical trial in people with mesothelioma indicate that an experimental chimeric antigen receptor-T cell therapy is safe and may provide benefit to patients, especially in combination with other immunotherapies.

Maintenance therapy with defactinib failed to improve survival following front-line chemotherapy in patients with merlin-low malignant pleural mesothelioma, according to results from the phase 2 COMMAND trial.

The Food and Drug Administration has approved the NovoTTF-100L System in combination with pemetrexed and platinum-based chemotherapy for the front-line treatment of patients with unresectable, locally advanced or metastatic malignant pleural mesothelioma.

An immunotherapy pair looks promising for those with pleural mesothelioma, which is now treated with chemotherapy.

Clinical trials of combination immunotherapy treatments are showing impressive overall survival rates.

After a shocking diagnosis, Heather Von St. James is on a mission to spread awareness about mesothelioma.

Immune checkpoint inhibitors have demonstrated encouraging results for patients with small cell lung cancer (SCLC) and mesothelioma, two aggressive thoracic malignancies with few options.

An ambitious clinical trial set to start in July will match patients to treatments based on molecular abnormalities, rather than cancer types, testing 20 targeted drugs at once.

Finding specialized care is worth the effort for patients with uncommon cancers.

Readers respond to past CURE articles on living with mesothelioma, hospice, beating bladder cancer, lung cancer, and response to CURE's 2007 Cancer Resource Guide.

Asbestos exposure is the main cause of mesothelioma, accounting for more than 80 percent of cases.